Medicare covers a continuous glucose monitor and the supplies that go with diabetes care for many enrollees, a benefit that can replace the daily cost and discomfort of finger-stick testing. A covered monitor, worn on the body, reads glucose continuously and sends the data to a receiver or a phone, and for qualifying beneficiaries Medicare treats the device and its sensors as durable medical equipment. The catch is eligibility: the coverage reaches people who meet specific medical criteria, not every enrollee who has diabetes.
What Medicare covers for diabetes
Medicare’s coverage of continuous glucose monitors extends to the device, its sensors and related supplies for beneficiaries who qualify. A monitor tracks glucose around the clock and can alert the user to dangerous highs and lows, information that a single finger-stick reading taken a few times a day cannot provide.
The benefit reaches well beyond the monitor itself. Part B also covers blood-sugar test strips, lancets, control solutions and standard blood-glucose meters as diabetes supplies, with quantity limits that rise for people who use insulin. The coverage treats these as the equipment and supplies a person manages the condition with day to day.
Cost-sharing follows the durable medical equipment rules. After the annual Part B deductible, a beneficiary generally pays 20% of the Medicare-approved amount for a covered monitor and supplies, as Medicare’s equipment coverage describes. A supplier must be enrolled in Medicare and accept assignment for the coverage to apply as expected.
Free retirement updates: A quiet rule change can shrink your Social Security or Medicare check, and no one warns you. The free Retirement Shield newsletter catches these early and tells you what to do. Get it free.
Who qualifies for a covered monitor
A continuous glucose monitor is not covered on request. Medicare requires that a treating clinician document a diagnosis of diabetes and confirm that the patient either uses insulin or has a history of problematic low blood sugar. The clinician must have evaluated the patient in person or by telehealth within the months before ordering the device, and must confirm that the person is able to use it.
Because the monitor is prescribed and dispensed through an enrolled supplier, the paperwork matters. A prescription that does not establish the qualifying condition, or a supplier outside Medicare’s network, can leave a beneficiary paying full price for a device that would otherwise be covered. Confirming both the medical documentation and the supplier before the device is ordered protects the coverage.
The eligibility net has also widened. Medicare once limited covered monitors to people who tested frequently and used multiple daily insulin doses, but the criteria now reach anyone treated with insulin at all, as well as certain beneficiaries with a history of problematic low blood sugar who use no insulin. That change brought the benefit to a much larger share of people managing diabetes than the older, narrower rule allowed. For someone who assumed a monitor was reserved for intensive insulin users, that broader standard is often the difference between paying out of pocket and paying only the coinsurance.
Beyond the monitor: training and nutrition counseling
Medicare’s diabetes coverage extends past devices and supplies to two education benefits that many enrollees never use. The first is diabetes self-management training, which Part B covers for people with a diabetes diagnosis and a doctor’s order. It pays for up to 10 hours of initial training — one hour individual and the rest in a group setting — in the first year, followed by up to two hours of follow-up training each year after that.
The second is medical nutrition therapy, one-on-one nutrition counseling delivered by a registered dietitian or other qualified nutrition professional. Medicare covers it for beneficiaries with diabetes or kidney disease, and for people who have had a kidney transplant within the previous three years, when a physician refers them. Like the training benefit, it renews on a yearly basis when the referral is in place.
Both benefits carry the standard Part B cost-sharing — the deductible and 20% coinsurance — but they can pay off out of proportion to their cost. Learning to interpret the readings from a continuous glucose monitor, and adjusting diet around them, is exactly the kind of instruction these benefits are designed to fund, turning a device into a plan a person can actually follow.
Why the coverage is worth claiming
For a person testing several times a day, the supplies add up, and a continuous monitor can replace much of that recurring expense while producing far better data. The device’s alerts can catch a dangerous low before it becomes an emergency, which carries its own financial stakes given the cost of an ambulance run or a hospital stay.
Continuous readings also let a clinician adjust medication and diet with more precision than periodic finger sticks allow. For enrollees managing insulin, that can mean fewer complications over time — the kind of slow, expensive damage that diabetes inflicts when blood-sugar swings go unseen between tests.
The practical takeaway is to check eligibility rather than assume exclusion. A beneficiary who uses insulin or has documented hypoglycemia, works with a Medicare-enrolled supplier, and has a clinician document the need can have the monitor and supplies covered at the standard 20% share — turning a benefit many never claim into a lower-cost, safer way to manage the condition.
This article was researched and drafted with the assistance of AI and reviewed by The Money Overview editorial team.
More Financial Reading
